Cancer Research UK logo.
SearchDonate
  • Search

A study looking at capecitabine chemotherapy doses in advanced breast or bowel cancer (DATACAP)

Overview

Cancer types:

Bowel (colorectal) cancer, Breast cancer, Colon cancer, Rectal cancer

Status:

Results

Phase:

Pilot

Details

This study looked at using a mobile phone programme to check on people’s side effects when they were taking a chemotherapy drug called capecitabine.

The researchers hoped this would help doctors manage side effects better, and decide when they could safely increase someone’s dose to help treat their cancer.

Recruitment start: 1 November 2009

Recruitment end: 30 November 2010

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Andrew Weaver

Supported by

NIHR Oxford Biomedical Research Centre

Oncology Clinical Trials Office (OCTO)

University of Oxford

Vodafone UK Foundation

Last reviewed: 11 September 2016

CRUK internal database number: 6253

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.